Transcription of Additional guidance on documents relating to an …
{{id}} {{{paragraph}}}
7 Westferry Circus Canary Wharf London E14 4HB United Kingdom An agency of the European Union Telephone +44 (0)20 7418 8400 Facsimile +44 (0)20 7418 8545 E-mail Website European Medicines Agency, 2012. Reproduction is authorised provided the source is acknowledged. 20 September 2012 EMA/CHMP/CVMP/QWP/549010/2012 Committee for Medicinal Products for Human Use (CHMP) Additional guidance on documents relating to an active substance master file Additional guidance on completing the Annex 2-letter of access, Annex 3-submission letter and administrative details for documents relating to an active substance master file and Annex 4-withdrawal of access letter of the active substance master file procedure guidance (CHMP/QWP/227/02 Rev 3, EMEA/CVMP/134/02 Rev 03)
Additional guidance on documents relating to an active substance master file EMA/CHMP/CVMP/QWP/549010/2012 Page 2/10 . When should each …
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}
Guideline on Active Substance Master File Procedure, Active Substance Master File, Master File, Active, STABILITY TESTING OF ACTIVE SUBSTANCES, STABILITY TESTING OF ACTIVE SUBSTANCES AND PHARMACEUTICAL PRODUCTS, FOR SUBMITTING APPLICATION FOR, M4Q Implementation Working Group Questions &, File, Harmonised Technical Guidance for Using, REGISTRATION